Residency · Los Angeles, CA
Sponsored by Keck School of Medicine of USC
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis.
The New England journal of medicine · 2024 · 1,637 citations · Mazen Noureddin
The global burden of metabolic disease: Data from 2000 to 2019.
Cell metabolism · 2023 · 651 citations · Mazen Noureddin
Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis.
The lancet. Gastroenterology & hepatology · 2023 · 618 citations · Mazen Noureddin
Genetic drivers of heterogeneity in type 2 diabetes pathophysiology.
Nature · 2024 · 489 citations · Thomas Buchanan
A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis.
The New England journal of medicine · 2024 · 417 citations · Mazen Noureddin
Consensus on diagnosis and management of Cushing's disease: a guideline update.
The lancet. Diabetes & endocrinology · 2021 · 765 citations · John Carmichael
Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma.
The New England journal of medicine · 2023 · 739 citations · Gino In
Multi-ancestry genetic study of type 2 diabetes highlights the power of diverse populations for discovery and translation.
Nature genetics · 2022 · 588 citations · Thomas Buchanan